PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.16%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.91%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
133.15%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
184.17%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
37.12%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
39.13%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
39.13%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.54%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.09%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.74%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-66.82%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-72.09%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
98.72%
10Y revenue/share CAGR above 1.5x ADI's 59.26%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
5.70%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
0.26%
3Y revenue/share CAGR at 50-75% of ADI's 0.45%. Martin Whitman would question if the firm lags behind competitor innovations.
177.32%
10Y OCF/share CAGR above 1.5x ADI's 79.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-32.68%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-43.52%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
367.16%
Net income/share CAGR above 1.5x ADI's 161.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-34.45%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-38.72%
Negative 3Y CAGR while ADI is 6.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
54.13%
10Y equity/share CAGR at 50-75% of ADI's 74.02%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
33.19%
Below 50% of ADI's 82.19%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
24.41%
Below 50% of ADI's 52.29%. Michael Burry suspects a serious short-term disadvantage in building book value.
846.73%
Dividend/share CAGR of 846.73% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
109.10%
5Y dividend/share CAGR above 1.5x ADI's 66.03%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
73.43%
3Y dividend/share CAGR 1.25-1.5x ADI's 49.96%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
8.37%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.24%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.81%
Negative asset growth while ADI invests at 1.72%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.46%
Under 50% of ADI's 3.80%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.05%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.41%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
6.74%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.